What Happened?
South San Francisco, CA-based Antiva-Biosciences Appointed Gail Maderis as President and Chief Executive Officer
About the Company
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva`s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
About the Person
Gail Maderis is President and Chief Executive Officer at Antiva Biosciences. Previously, Gail held various senior HR leadership roles in the industry.
Info Source
News
Short Profile